22 New Autoclave Range at Lab Innovations


In November, on stand B72 at Lab Innovations, British autoclave manufacturer Priorclave, is expected to reveal details of entirely new research and laboratory grade autoclave ranges.


The company will continue to produce small benchtop models from 40L capacity to large 850L capacity chamber autoclaves. However, within the various new developments, each range will have more features and benefits that come as standard. This will make it easier for customers to select the best autoclave-match for their specific sterilising application.


Autoclave models in the new ranges will still appeal to the same diverse customer base involved in food and drink, dairy, pharmaceutical, agriculture, education, healthcare and research establishments. And they will continue to offer a superior anti-microbial exterior finish to body panels and frames. This is a highly effective and permanent treatment for lifelong control of harmful bacteria and protection against the threat of cross contamination. This tough special epoxy finish is proven to reduce bacterial growth by up to 99.99% and is highly effective against MRSA, E.coli, Listeria, Legionella, Campylobacter, Salmonella, Pseudomonas and over 50 other species.


Each model will incorporate the very latest version of Tactrol® , a microprocessor controller developed by Priorclave for easy programming of the sterilising cycle. Priorclave is renowned for the build quality of its steam sterilisers, their durability and reliability. The high standards maintained at every stage of production


ensures the operational longevity of every research grade laboratory autoclave that leaves the UK manufacturing centre. And all supported by first class before and after sales, technical support. Priorclave can assure customers that the level of dedication applied to achieving what is considered the best autoclave build and program functionality, will be maintained through the new autoclave ranges. More information online: ilmt.co/PL/VZ4E


56225pr@reply-direct.com


Quantitative Analysis of Microplastics in Seawater Using Pyrolysis and GCMS


Over 300 million tons of plastics are manufactured every year and studies have shown that >10% of these eventually entered and contaminated the ocean. Growing attention on microplastics in sea water with <5 mm diameter size has been increasing with many surveys on measuring these using FTIR and Raman technologies.


Many analytical techniques only provide limited information on polymer type and size and are not capable in offering an accurate weight percentage of the pollutants. A GCMS pyrolysis technique has been developed by CDS to overcome these limitations.


A previous application described the identification of microplastics in the sea water over ppm concentration using a CDS pyrolysis system from Analytix coupled with a GCMS. This application note is a continued study to further quantify the microplastics concentration and describes using polymer marker peaks for calibration and quantification.


Download both application notes now. More information online: ilmt.co/PL/Q6OP


55964pr@reply-direct.com


Positive and Negative Pressure Isolators Expands Product Portfolio


Following the successful appointment as exclusive distributor of Faster srl airflow products to mainland UK in 2019, Biopharma Group has been invited to add positive and negative pressure isolators to their Faster product offering. This is an exciting addition as it presents opportunities to assist new areas of the industry previously not covered by other products.


At Biopharma Group, teams work with businesses and institutions across the UK to meet their operational, environmental and financial requirements including the provision of consultation and advice on the right lab products for you, your practices and applications. Faster Air manufacture the highest specification equipment and the company are delighted to welcome the following new products to the range for 2021:


GloveFAST Aseptic Isolator - A positive pressure isolator with vertical laminar airflow. Adopted in many sectors of industry and science laboratories for use in pharmaceutical applications and/or when handling cell cultures or non-pathogenic biological specimens. The GloveFAST aseptic isolator is recommended for applications such as quality control, microbiology, cell culture, sterility testing, aseptic manipulation, small scale production, TPN, IV solutions, weighing and dosing.


GloveFAST Cyto & GloveFAST Cyto Pharma Isolators are negative pressure isolators with vertical laminar airflow. They are suitable for the treatment of hazardous products and wherever a product-personnel-environment cross-protection is required. These isolators are specially suitable for applications such as Cytotoxic and CMR preparations, small scale production of cytotoxic or toxic drugs, weighing and dosing.


Contact Biopharma to speak to their specialist team about isolators or any other product in the Faster range. More information online: ilmt.co/PL/QovJ


56460pr@reply-direct.com


An Improved Method for the Prevention and Control of Outbreaks of Legionnaires’ Disease IDEXX has welcomed the publication of a study carried out by the Public Health Laboratory of L’Hospitalet in Barcelona, Spain, which compared the IDEXX Legiolert®


detection and enumeration of Legionella (ISO 11731).


Comparing the methods in both potable and non-potable water samples according to the rigorous ISO 17994 protocol, the study found that Legiolert detected more positive results than ISO 11731 and was statistically more sensitive for Legionella pneumophila.


Additionally, Legiolert was compared to ISO 11731 for the detection of all Legionella species, and while ISO 17994 results demonstrate the two methods to be statistically equivalent, Legiolert was found to be more sensitive.


The study found that all Legiolert results were confirmed to be Legionella pneumophila, indicating a specificity of 100% and no false positives. The authors of the study also noted the procedural advantages of Legiolert, and suggest that it is an easier-to-use test that could be performed more frequently than the standard ISO 11731 method.


Legiolert uses bacterial enzyme detection technology to identify and enumerate Legionella pneumophila, the principal cause of Legionnaires’ disease. This latest study is notable because it shows that despite being specific to Legionella pneumophila, Legiolert even outperforms ISO 11731 when other Legionella species results are included.


These results convinced the study authors to utilise Legiolert instead of the traditional plate method whenever possible in order to minimise the risk of Legionnaires´ disease in their community.


Full details of the study can be found here: ilmt.co/PL/5OYP More information online: ilmt.co/PL/JQZg


55950pr@reply-direct.com


test with the standard method for


LABMATE UK & IRELAND - NOVEMBER 2021


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56